Loading…

Radiotherapy-induced Cardiac Implantable Electronic Device Dysfunction in Patients with Cancer

Abstract Radiotherapy can affect the electronic components of a cardiac implantable electronic device (CIED) resulting in malfunction and/or damage. We sought to assess the incidence, predictors and clinical impact of CIED dysfunction (CIED-D) following radiotherapy for cancer treatment. Clinical ch...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2017-01, Vol.119 (2), p.284-289
Main Authors: Bagur, Rodrigo, MD, PhD, Chamula, Mathilde, MD, Brouillard, Émilie, MD, Lavoie, Caroline, MD, Nombela-Franco, Luis, MD, PhD, Julien, Anne-Sophie, MSc, Archambault, Louis, PhD, Varfalvy, Nicolas, PhD, Gaudreault, Valérie, MD, PhD, Joncas, Sébastien X., MD, Israeli, Zeev, MD, Parviz, Yasir, MBBS, Mamas, Mamas A., DPhil, Lavi, Shahar, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Radiotherapy can affect the electronic components of a cardiac implantable electronic device (CIED) resulting in malfunction and/or damage. We sought to assess the incidence, predictors and clinical impact of CIED dysfunction (CIED-D) following radiotherapy for cancer treatment. Clinical characteristics, cancer and different types of CIEDs as well as radiation-dose were evaluated. The investigation identified 230 patients; mean age 78±8 years and 70% were male. A total of 199 (86%) patients had pacemakers (59% dual-chamber), 21 (9%) cardioverter-defibrillators and 10 (4%) resynchronizators/defibrillators. The left pectoral (n=192, 83%) was the most common CIED location. Sixteen (7%) patients experienced 18 events of CIED-D after radiotherapy. Reset to back-up pacing mode was the most common encountered dysfunction, and only 1 (6%) patient of those with CIED-D experienced symptoms of atrio-ventricular dys-synchrony. Those who had CIED-D had a shorter device-age at the time of radiotherapy compared to those who did not (2.5±1.5 vs. 3.8±3.4 years, P =0.005). The total dose prescribed to the tumor (66±30 vs. 42±23 Gy) was significantly higher among those who had CIED-D (P
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2016.09.036